Health-related quality of life in colorectal cancer

Colorectal Disease

Volumn 15, Issue 5, 2013, Pages

  Farkkila N ^a,b   Sintonen, H ^a   Saarto, T ^c   Jarvinen H ^c   Hanninen J ^d   Taari, K ^a,c   Roine, R P ^e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b GLAXOSMITHKLINE   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Terhokoti   (Finland)

^e HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA   (Finland)

Author keywords

15D; Colorectal cancer; Disease states; EORTC QLQ C30; EQ 5D; Health related quality of life (HRQoL)

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; COLORECTAL CANCER; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PAIN; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PALLIATIVE CARE; QUALITY OF LIFE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS;

EID: 84877003982     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12143     Document Type: Article

References (14)

1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765-81.
2. Finnish Cancer Registry, Cancer Statistics at www.cancerregistry.fi, updated on 01.03.2012.
3. Cunningham D, Atkin W, Lenz HJ et al. Colorectal cancer. Lancet 2010; 375: 1030-47.
4. Aromaa A, Koskinen S. Health and functional capacity in Finland. Baseline results of the Health 2000 health examination survey. Series B 12/2004. 2004. Publications of National Public Health Institute 2004:171.
5. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med 2001; 33: 328-36.
6. Sintonen H. Outcome Measurement in Acid-Related Diseases. PharmacoEconomics 1994; 5: 17-26.
7. Group EuroQol. EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16: 199-208.
8. Pickard AS, Neary M, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health and Quality of Life Outcomes 2007; 5: 70.
9. Aaronson N, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
10. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A on behalf of the EORTC Quality of Life Group (2001) 3rd edition The EORTC QLQ-C30 Scoring Manual. European Organisation for Research and Treatment of Cancer, Brussels.
11. Saarni SI, Härkänen T, Sintonen H et al. The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res 2006; 15: 1403-14.
12. Hamashima C. Long-term quality of life of postoperative rectal cancer patients. J Gastroenterol Hepatol 2002; 17: 571-6.
13. Jansen L, Koch L, Brenner H, Arndt V. Quality of life among long-term (≥5 years) colorectal cancer survivors-systematic review. Eur J Cancer 2010; 46: 2879-88.
14. Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H. Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: a population based study. Eur J Cancer 2006; 42: 1848-57.